Anteris Technologies Global (AVR) Competitors $3.92 -0.14 (-3.45%) As of 08/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock AVR vs. DCTH, BFLY, TMCI, RXST, SNWV, NPCE, STIM, CLPT, CATX, and OMShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Delcath Systems (DCTH), Butterfly Network (BFLY), Treace Medical Concepts (TMCI), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Neuronetics (STIM), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. Its Competitors Delcath Systems Butterfly Network Treace Medical Concepts RxSight Sanuwave Health NeuroPace Neuronetics ClearPoint Neuro Perspective Therapeutics Outset Medical Anteris Technologies Global (NASDAQ:AVR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Is AVR or DCTH more profitable? Delcath Systems has a net margin of 3.18% compared to Anteris Technologies Global's net margin of 0.00%. Delcath Systems' return on equity of 6.91% beat Anteris Technologies Global's return on equity.Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A Delcath Systems 3.18%6.91%5.80% Do institutionals and insiders believe in AVR or DCTH? 61.1% of Delcath Systems shares are held by institutional investors. 17.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer AVR or DCTH? Anteris Technologies Global presently has a consensus target price of $16.50, indicating a potential upside of 320.92%. Delcath Systems has a consensus target price of $24.50, indicating a potential upside of 134.00%. Given Anteris Technologies Global's higher possible upside, equities research analysts clearly believe Anteris Technologies Global is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, AVR or DCTH? Delcath Systems has higher revenue and earnings than Anteris Technologies Global. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.70M52.35-$76.29MN/AN/ADelcath Systems$37.21M9.84-$26.39M$0.05209.40 Does the media favor AVR or DCTH? In the previous week, Delcath Systems had 11 more articles in the media than Anteris Technologies Global. MarketBeat recorded 19 mentions for Delcath Systems and 8 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.40 beat Delcath Systems' score of 0.23 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Delcath Systems 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDelcath Systems beats Anteris Technologies Global on 8 of the 11 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$146.41M$7.07B$5.62B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E RatioN/A25.4830.2925.74Price / Sales52.3573.48463.41115.83Price / CashN/A21.9738.2159.48Price / Book5.855.388.826.15Net Income-$76.29M$176.29M$3.25B$265.06M7 Day Performance8.29%3.21%3.71%2.60%1 Month Performance35.17%1.49%5.85%2.83%1 Year PerformanceN/A10.20%29.92%25.58% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies GlobalN/A$3.92-3.4%$16.50+320.9%N/A$146.41M$2.70M0.00138News CoverageEarnings ReportDCTHDelcath Systems2.6732 of 5 stars$10.50-2.3%$24.00+128.5%+42.3%$365.78M$53.85M-21.0160Short Interest ↑BFLYButterfly Network2.5074 of 5 stars$1.45-15.5%$3.50+142.2%+50.4%$357.33M$85.63M-4.98460Gap UpTMCITreace Medical Concepts2.5039 of 5 stars$5.33-0.8%$10.52+97.5%+27.1%$334.58M$209.36M-6.26250Earnings ReportRXSTRxSight1.4908 of 5 stars$7.75-0.4%$17.50+125.8%-83.9%$315.41M$139.93M-11.58220Trending NewsEarnings ReportShort Interest ↑SNWVSanuwave Health2.5198 of 5 stars$35.86-6.8%$49.00+36.6%N/A$307.32M$32.63M-7.8740Earnings ReportNPCENeuroPace3.35 of 5 stars$8.94+5.1%$17.00+90.2%+33.4%$293.23M$79.91M-10.64170News CoveragePositive NewsEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionSTIMNeuronetics2.2553 of 5 stars$4.38-0.3%$5.50+25.7%+329.0%$289.23M$74.89M-3.34180Gap DownCLPTClearPoint Neuro1.7169 of 5 stars$9.96-4.2%$19.67+97.4%+18.8%$278.60M$32.24M-13.10110Positive NewsEarnings ReportGap DownCATXPerspective Therapeutics1.6841 of 5 stars$3.75-2.3%$12.56+234.8%-70.8%$278.36MN/A0.0070OMOutset Medical1.7737 of 5 stars$15.17-5.5%$29.50+94.5%+3.2%$269.91M$115.27M-0.52520 Related Companies and Tools Related Companies DCTH Alternatives BFLY Alternatives TMCI Alternatives RXST Alternatives SNWV Alternatives NPCE Alternatives STIM Alternatives CLPT Alternatives CATX Alternatives OM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access